The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Biomarkers, 2009High Resolution Diffusion Tensor Imaging in Parkinson's Disease and Parkinson Plus Syndromes
Objective/Rationale:
An objective and valid trait and state biomarker of Parkinson’s disease will help therapeutic development by providing a measure to help confirm diagnosis (trait), and track... -
Rapid Response Innovation Awards, 2009Possibility of Small Molecule Activation of PINK1 Kinase Activity
Objective/Rationale:
Many genetic disorders are caused by the loss of a functional protein which protects cells from disease. These disorders are difficult to treat with drugs because most drugs block... -
MJFF Research Grant, 2009Supplemental Biomarkers Study to Clinical Trial for CoQ10
Objective/Rationale:
There is a critical need for biomarkers of Parkinson’s disease (PD), for accurate and earlier diagnosis, and for monitoring treatment effects. We are investigating two potential... -
MJFF Research Grant, 2009Assessing Heart Rate Variability (HRV) in the Parkinson's Associated Risk Study (PARS) Cohort
Objective/Rationale:
The objective of this study is to determine if HRV, which is reduced in PD, is significantly reduced in subjects with hyposmia (loss of smell) compared to subjects who are... -
Rapid Response Innovation Awards, 2009Validating the Electrocardiogram as a Tool to Identify Pre-motor Parkinson's Disease
Promising Outcomes of Original Grant:
Our goal in the funded RRIA was to determine if a 5 minute EKG recordings in patients with a high probably of having pre-motor PD, i.e., individuals with... -
Research Grant, 2009Biomarkers of Pioglitazone Effects in Parkinson's Disease (BioPEP)
Objective/Rationale:
Pioglitazone is a medication used to treat diabetes that that has shown promise in laboratory studies for potentially slowing the progression of Parkinson’s disease (PD). The...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.